Study Stopped
Funding not secured
Multicenter Exploratory Study of Accelerometry in Dilated Cardiomyopathy
MESA-DCM
A Multicenter Exploratory Study of Accelerometry Measurements in Dilated Cardiomyopathy Patients
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Study evaluates the relationships between daily physical activity levels (PAL) and functional capacity (VO2peak) in patients with dilated cardiomyopathy (DCM)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedAugust 13, 2019
August 1, 2019
7 months
June 27, 2017
August 9, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
VO2max correlation with daily physical activity
Maximal exercise capacity as measured by Max VO2 via CPET correlation with wearable device measures of daily physical activity
2 weeks
Secondary Outcomes (2)
NYHA correlation with daily step count
2 weeks
KCCQ correlation with daily step count
2 weeks
Study Arms (1)
Standard
EXPERIMENTALAll participants will perform the CPET at Baseline visit and will be provided with the Cardea SOLO, ActiGraph wGT3X-BT and Wavelet Wristband. The participants will be asked to response to KCCQ and Stanford 7 day recall surveys.
Interventions
Participants will be asked to wear everyday for 7 days after the Baseline visit. the monitor attaches to the skin with adhesive and records heart rate and heart rhythm.
Participants will be asked to wear everyday for 2 weeks after the Baseline visit. The wearable tracks activity and the step count during the day.
Participants will be asked to wear everyday for 2 weeks after the Baseline visit. The wearable measures the activity and the heart rate as measured by PPG sensor.
Eligibility Criteria
You may qualify if:
- Males and females, 18-75 years of age
- Diagnosis of dilated cardiomyopathy
- (Unexplained left ventricular enlargement (left ventricular end diastolic dimension (LVEDD) \>95th percentile for gender and height by echo or MRI)
- (Left ventricular ejection fraction (LVEF) less than 50%)
- CPET within 14 days prior to baseline visit with no intervening change in therapy
- Echocardiogram or cardiac MRI within 1 year prior to baseline
- Able to walk \>100ft without limitation
- More than 30 minutes of exercise per week for at least 3 months prior to study enrollment, and plan to continue exercising for the next two weeks (duration of study).
- Ability to provide informed consent and willingness to complete the study (including weekly phone follow-up)
You may not qualify if:
- Heart failure hospitalization within four weeks prior to enrollment
- Non-cardiac limitation of activity
- \. Prior exercise-induced syncope or exercise-induced sudden death 5. Primary exercise mode is swimming or stationary biking 6. Participation in competitive or high intensity exercise against medical advice 7. Implantable Cardiverter Defibrillator (ICD) placement in the 2 months prior to enrollment 8. Plan for surgery, device implantation, or significant change in clinical management during the two weeks of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew T Wheeler, MD PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
June 27, 2017
First Posted
July 2, 2017
Study Start
August 1, 2017
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
August 13, 2019
Record last verified: 2019-08